vs
Side-by-side financial comparison of Cardiff Oncology, Inc. (CRDF) and Sintx Technologies, Inc. (SINT). Click either name above to swap in a different company.
Sintx Technologies, Inc. is the larger business by last-quarter revenue ($290.0K vs $243.0K, roughly 1.2× Cardiff Oncology, Inc.). Sintx Technologies, Inc. runs the higher net margin — -763.8% vs -2969.5%, a 2205.8% gap on every dollar of revenue. On growth, Cardiff Oncology, Inc. posted the faster year-over-year revenue change (62.0% vs -46.5%). Over the past eight quarters, Cardiff Oncology, Inc.'s revenue compounded faster (8.9% CAGR vs -35.0%).
Sintx Technologies, Inc. is an advanced materials company specializing in R&D and manufacturing of high-performance silicon nitride and other technical ceramic products. It serves key segments including medical implants, aerospace & defense, industrial wear components, and electric vehicle applications, with core markets across North America, Europe and Asia-Pacific.
CRDF vs SINT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $243.0K | $290.0K |
| Net Profit | $-7.2M | $-2.2M |
| Gross Margin | — | 64.8% |
| Operating Margin | -3221.0% | -799.3% |
| Net Margin | -2969.5% | -763.8% |
| Revenue YoY | 62.0% | -46.5% |
| Net Profit YoY | 38.8% | -30.7% |
| EPS (diluted) | $-0.11 | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $243.0K | $290.0K | ||
| Q3 25 | $120.0K | $208.0K | ||
| Q2 25 | $121.0K | $151.0K | ||
| Q1 25 | $109.0K | $369.0K | ||
| Q4 24 | $150.0K | $542.0K | ||
| Q3 24 | $165.0K | $799.0K | ||
| Q2 24 | $163.0K | $859.0K | ||
| Q1 24 | $205.0K | $687.0K |
| Q4 25 | $-7.2M | $-2.2M | ||
| Q3 25 | $-11.3M | $-3.5M | ||
| Q2 25 | $-13.9M | $-2.3M | ||
| Q1 25 | $-13.4M | $-2.3M | ||
| Q4 24 | $-11.8M | $-1.7M | ||
| Q3 24 | $-11.9M | $-6.2M | ||
| Q2 24 | $-11.8M | $-2.2M | ||
| Q1 24 | $-10.0M | $-886.0K |
| Q4 25 | — | 64.8% | ||
| Q3 25 | — | 44.7% | ||
| Q2 25 | — | 37.7% | ||
| Q1 25 | — | 33.3% | ||
| Q4 24 | — | 71.6% | ||
| Q3 24 | — | 73.7% | ||
| Q2 24 | — | 73.9% | ||
| Q1 24 | — | 67.5% |
| Q4 25 | -3221.0% | -799.3% | ||
| Q3 25 | -9978.3% | -1613.0% | ||
| Q2 25 | -12212.4% | -1764.9% | ||
| Q1 25 | -13194.5% | -645.8% | ||
| Q4 24 | -8381.3% | -319.6% | ||
| Q3 24 | -7637.0% | -802.0% | ||
| Q2 24 | -7696.3% | -315.5% | ||
| Q1 24 | -5333.2% | -465.4% |
| Q4 25 | -2969.5% | -763.8% | ||
| Q3 25 | -9381.7% | -1701.4% | ||
| Q2 25 | -11523.1% | -1535.1% | ||
| Q1 25 | -12324.8% | -621.1% | ||
| Q4 24 | -7858.0% | -312.7% | ||
| Q3 24 | -7184.8% | -780.9% | ||
| Q2 24 | -7225.8% | -256.6% | ||
| Q1 24 | -4883.4% | -129.0% |
| Q4 25 | $-0.11 | $-0.50 | ||
| Q3 25 | $-0.17 | $-3.46 | ||
| Q2 25 | $-0.21 | $-0.91 | ||
| Q1 25 | $-0.20 | $-1.29 | ||
| Q4 24 | $-0.22 | $17.04 | ||
| Q3 24 | $-0.25 | $-6.96 | ||
| Q2 24 | $-0.26 | $-3.61 | ||
| Q1 24 | $-0.22 | $-21.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $58.3M | $4.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $45.4M | $2.9M |
| Total Assets | $61.9M | $9.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $58.3M | $4.1M | ||
| Q3 25 | $60.6M | $6.3M | ||
| Q2 25 | $71.0M | $4.3M | ||
| Q1 25 | $79.9M | $6.5M | ||
| Q4 24 | $91.7M | $3.6M | ||
| Q3 24 | $57.7M | $4.8M | ||
| Q2 24 | $60.3M | $4.6M | ||
| Q1 24 | $67.2M | $5.8M |
| Q4 25 | $45.4M | $2.9M | ||
| Q3 25 | $48.8M | $4.1M | ||
| Q2 25 | $58.6M | $4.0M | ||
| Q1 25 | $70.9M | $6.1M | ||
| Q4 24 | $82.9M | $3.9M | ||
| Q3 24 | $49.4M | $5.6M | ||
| Q2 24 | $52.4M | $8.8M | ||
| Q1 24 | $60.9M | $9.9M |
| Q4 25 | $61.9M | $9.5M | ||
| Q3 25 | $63.8M | $11.4M | ||
| Q2 25 | $75.7M | $9.2M | ||
| Q1 25 | $84.8M | $11.4M | ||
| Q4 24 | $97.2M | $9.4M | ||
| Q3 24 | $62.9M | $11.3M | ||
| Q2 24 | $66.1M | $15.3M | ||
| Q1 24 | $74.0M | $17.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $-2.3M |
| Free Cash FlowOCF − Capex | — | $-2.4M |
| FCF MarginFCF / Revenue | — | -822.8% |
| Capex IntensityCapex / Revenue | — | 14.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $-2.3M | ||
| Q3 25 | $-10.8M | $-2.5M | ||
| Q2 25 | $-8.3M | $-2.4M | ||
| Q1 25 | $-12.8M | $-1.3M | ||
| Q4 24 | $-10.3M | $-1.1M | ||
| Q3 24 | $-10.5M | $-2.6M | ||
| Q2 24 | $-9.2M | $-2.2M | ||
| Q1 24 | $-7.7M | $-2.7M |
| Q4 25 | — | $-2.4M | ||
| Q3 25 | $-10.9M | $-2.6M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-1.4M | ||
| Q4 24 | — | $-1.3M | ||
| Q3 24 | — | $-2.6M | ||
| Q2 24 | — | $-2.6M | ||
| Q1 24 | $-7.8M | $-2.9M |
| Q4 25 | — | -822.8% | ||
| Q3 25 | -9043.3% | -1250.5% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -368.6% | ||
| Q4 24 | — | -234.3% | ||
| Q3 24 | — | -323.0% | ||
| Q2 24 | — | -299.7% | ||
| Q1 24 | -3814.6% | -423.1% |
| Q4 25 | — | 14.5% | ||
| Q3 25 | 15.0% | 40.4% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 16.0% | ||
| Q4 24 | 0.0% | 26.9% | ||
| Q3 24 | 0.0% | 1.4% | ||
| Q2 24 | 0.0% | 41.8% | ||
| Q1 24 | 39.0% | 25.3% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
